Africa is switching to HIV injection with 99.9% effectiveness: a new stage of prevention
South Africa, Zambia and Eswatini have launched large—scale use of an innovative HIV prevention drug, lenacapavir, with an efficacy exceeding 99.9%. The injection, which is required only twice a year, is considered one of the most serious breakthroughs in the field of public health and can radically change the approach to combating the spread of HIV in the region.